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ABSTRACT 
 
The purposes of the present study were 1) to assess the health related quality 
of life (HRQOL) and the subjective health status in a sample of HIV-infected 
persons, 2) to relate the results to different male population groups and 3) to 
investigate the relationship of medical and demographic variables with 
HRQOL. A total of 72 HIV-infected men were included. They answered the 
Swedish Health-Related Quality of Life Questionnaire and the Health Index. 
Demographic and medical data were obtained from the medical records. The 
data collection took place before entering a therapeutic HIV vaccine trial. The 
results showed a more negative impact on the HRQOL and subjective health 
status in the HIV-positive subjects, compared with male population groups. 
The dimensions of emotional well-being were most affected. When comparisons 
were made according to the medical and demographic variables for different 
subgroups within the HIV sample, differences in the physical-dimension scales 
were most prominent. Symptomatic HIV infection or AIDS, anti-retroviral 
treatment, sick leave or disability pension, low income and basic education 
were associated with worse HRQOL and health status. In conclusion, it is of 
the utmost importance to take into account aspects of the patients’ emotional 
well-being in nursing, as well as in medical care and interventions. Moreover, 
individualised caring programs are needed since the disruptions in HRQOL 
fluctuated within the HIV sample. 
 
Keywords: Quality of life, health status, HIV infection, AIDS, CD4, 
antiretroviral therapy, SWED-QUAL, HI 
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INTRODUCTION 
 
In recent decades, the health-related quality of life (HRQOL) has increasingly 
gained importance as an outcome measure in health care (Guyatt et al. 1993; 
Testa & Simonson 1996), especially as regards interventions for patients with 
various chronic diseases (Patrick & Eriksson 1993). 
 
The Human Immunodeficiency Virus Type 1 (HIV) is a retrovirus which 
causes chronic, progressive, immunological dysfunction. Infection with HIV is 
characterised by a long period with no or minor symptoms, but the virus 
causes declining levels of T-helper (CD4-positive) lymphocytes. Low levels of 
CD4-positive lymphocytes are associated with increased risk of the Acquired 
Immunodeficiency Syndrome (AIDS), defined by opportunistic infections and 
HIV-related cancers. HIV infection is also associated with different 
psychological and neuropsychiatric disorders. Today, there is no cure against 
HIV infection. Treatment is concentrated on delaying the HIV’s suppression of 
the immune system and on controlling and or preventing opportunistic 
infections and cancers (Catalan 1990; Saag 1994). 
 
Globally, the estimated number of persons infected with HIV since the 
beginning of the pandemic is 30.6 million, of whom over 12.9 million have 
developed AIDS (World Health Organization 1997) and the estimate for the 
end of the century is more than 40 million infected people (UNAIDS/WHO 
Working Group on Global HIV/AIDS and STD Surveillance 1997). The 
reported number of HIV-infected individuals in Sweden is 4,737 (1,571 AIDS), 
of whom 994 have died (Swedish Institute for Infectious Disease Control 1998), 
and approximately one new case is reported each day. Out of the Swedish HIV-
carriers, the reported mode of transmission is male to male sex (42%), male to 
female sex (35%), intravenous drug use (16%), blood products (4%), mother to 
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child (1%) and other or unknown (2%) (Swedish Institute for Infectious Disease 
Control 1998). 
 
HIV infection affects several HRQOL domains, and studies of HIV and the 
quality of life have shown that, compared with patients with various other 
chronic conditions, patients with symptomatic HIV scored their HRQOL as 
poorer, while patients with asymptomatic HIV scored it better (Wu et al. 1991; 
Wachtel et al. 1992). Of the HIV patients in different disease stages, 
asymptomatic patients scored their HRQOL better than symptomatic HIV 
carriers (Ragsdale & Morrow 1990; Wu et al. 1990; Wachtel et al. 1992). The 
most affected group seemed to be the group of patients with AIDS-related 
complex (ARC) (Ragsdale & Morrow 1990). In a qualitative study of 25 HIV 
patients, Laryea & Gien found indications that the investigated patients felt 
doubly stigmatised and ”that the HIV-positive diagnosis had a profound 
impact on the individual’s psycho-social aspects of life” (Laryea & Gien 1993 p. 
245). Similarly, Ragsdale & Morrow found in their study of 95 HIV patients in 
various disease stages that the psycho-social dimension seemed to be the most 
affected (Ragsdale & Morrow 1990).  
 
Several studies have focused on the quality of life of HIV-positive individuals 
(Hays & Shapiro 1992; Wu & Rubin 1992; Wu & Rubin 1994; Holzemer & 
Wilson 1995), but comparisons with general population samples have been 
unusual. Most HIV-carriers are treated in out patient clinics and many of 
them are judged as symptom free. Therefore the specific aims of the present 
study were to assess the HRQOL and the subjective health status of an out 
patient sample of HIV-infected persons and to relate these results to different 
general population groups and medical and demographic variables. 
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METHODS 
 
Instruments 
 
The participants were asked to complete two questionnaires regarding their 
HRQOL and subjective health status. These questionnaires are designed for 
self-administration and were answered before entering a therapeutic HIV 
vaccine trial. In addition, demographic and medical data were obtained from 
specific questions added to the instruments and from the medical records. The 
following instruments were used. 
 
The Swedish Health-Related Quality of Life Questionnaire (SWED-QUAL) 
 
The SWED-QUAL was developed by Brorsson, Ifver & Hays (Brorsson et al. 
1993) from the measures used in the USA Medical Outcomes Study (MOS) 
(Stewart et al. 1988; Tarlov et al. 1989; Stewart et al. 1992; Ware & 
Sherbourne 1992). The questionnaire is designed to measure the HRQOL and 
consists of 70 items, of which 63 form two single-item and 11 multi-item 
dimension scales of Likert type: physical functioning (7 items), mobility (1 
item), satisfaction with physical ability (1 item), role limitations due to 
physical health (3 items), pain (6 items), positive affect (6 items), negative 
affect (in this study expressed as ”absence of negative affect” (6 items)), role 
limitations due to emotional health (3 items), sleep problems (7 items), 
satisfaction with family life (relations with parents, siblings, children etc. (4 
items)), relation to partner (6 items), sexual functioning (4 items) and general 
health perception (9 items). The relation to partner section was, in the present 
study, slightly modified to make it usable for the investigated group (i.e. the 
word ”spouse” was replaced by ”partner”). Each separate scale is transformed 
into a 0-100 index. The higher the score, the better the perceived HRQOL. In a 
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general population sample, the internal-consistency reliability coefficients 
(Cronbach’s ) ranged from 0.79 to 0.89. Brorsson et al. have also reported 
preliminary support for the construct validity (Brorsson et al. 1993). 
Furthermore, the SWED-QUAL has been used in several populations of 
Swedish patients (Larsen et al. 1996; Wändell et al. 1997a; Wändell et al. 
1997b; Lindqvist & Sjödén 1998). 
 
Health Index (HI) 
 
The HI questionnaire, first published by Nordström et al. 1992, consists of 10 
items concerning energy, temper, fatigue, loneliness, sleep, vertigo, bowel 
function, pain, mobility and general health. For each statement, the 
participants were asked to rate their health status during the previous week 
on a four-grade Likert scale, which ranged from 1 to 4 (very poor to very good). 
The scores are summarised to form a health index ranging from 10 to 40. The 
higher the score, the better the self-rated health (Nordström et al. 1992).  
 
A factor analysis performed by Nordström et al. defined two factors: emotional 
well-being (EWB), consisting of four items (energy, temper, fatigue and 
loneliness), and physical well-being (PWB), consisting of five items (mobility, 
sleep, vertigo, bowel function and pain). The general health item was related 
to general well-being and was thus excluded from the specific subsets 
(Nordström et al. 1992). 
 
The HI has been tested for reliability in different patient populations with 
satisfactory results (Cronbach’s  0.77 to 0.85) (Nordström et al. 1992; Langius 
et al. 1993; Forsberg 1996) Data from a Stockholm population group showed a 
Cronbach’s  of 0.74 (Forsberg & Björvell 1993). The instrument also have 
shown to have discriminant validity (Nordström et al. 1992). 
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The SWED-QUAL instrument was selected because it derives from an 
internationally used instrument, tested for reliability and validity in Sweden 
and because data from a Swedish reference group are available (Brorsson et al. 
1993). The HI was used because it is short and includes items not found in the 
SWED-QUAL. Moreover, the HI has been used in a Stockholm population 
group (Forsberg & Björvell 1993).  
 
Subjects 
 
The subjects were recruited from a group of patients who were entering a 
pharmaceutical study of a therapeutic HIV vaccine at the Stockholm Söder 
Hospital. The inclusion criteria were HIV seropositivity, an estimated CD4 
count of >200 x 106 cells/l based on previous test results (i.e. >300 x 106 cells/l 
within 3 months or >200 x 106 cells/l within 1 month prior to study entry), age 
>15 years, a judgement that the patient was able to complete blood tests and 
other procedures required and absence of current acute disease, leucopenia, 
thrombocytopenia, hepatic abnormality, hypersensitivity to insect cells or 
baculo virus, pregnancy or plans to be pregnant during the coming two years 
or drug or alcohol abuse, neurological or psychiatric dysfunction which could 
negatively interfere with the patient’s ability to participate in the study. 
Further details regarding the patient selection for the therapeutic trial have 
been presented elsewhere (Sandström & Wahren 1999).  
 
Oral and written information about the study were given to the patients in 
connection to an ordinary, scheduled visit to the clinic. If they agreed to 
participate, they were asked to complete the questionnaires, marked with an 
anonymous identification number, and to return them in a closed envelope. 
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During the period August 1993 to April 1995, a total of 86 HIV-infected male 
out-patients were eligible for this study and 72 were included (2 declined to 
enter the vaccine trial, 3 were, by mistake, not asked to participate in this 
study, 1 was excluded owing to difficulties understanding the Swedish 
language and 8 declined participation in the present study).  
 
All the participants (n=72) had HIV seropositive status documented by at least 
two laboratory tests (two repeated ELISA tests or one ELISA test and one 
Western Blot investigation).  
 
Population groups 
 
The SWED-QUAL questionnaire has been used in a sample of Swedish 
citizens (n=1443) (Brorsson et al. 1993). Details regarding the selection 
procedure have been presented by Brorsson et al. 1993. From this group, the 
results from men in the age-range 20-64 years, corresponding to that of the 
study population, were extracted and used for comparison (Swedish population 
group (n=390) (Brorsson, B. (1999) Personal communication)). 
 
For comparison of the HI, a reference group of randomly selected, healthy 
persons living in Stockholm County, Sweden, was used (n=180) (Forsberg & 
Björvell 1993). Details regarding the selection procedure have been presented 
elsewhere (Forsberg & Björvell 1993). From this group, the results from men 
in the age-range  26-65 years were extracted and used for comparison 
(Stockholm population group, n=60). 
 
Definitions 
 
The demographic and medical variables are defined as follows: 
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Classification of subjects with diagnosed HIV are defined according to the 
Centers for Disease Control (CDC) at the U.S. Department of Health and 
Human Services (1986) (Centers for infectious disease control 1986): Group I, 
acute infection; group II, asymptomatic infection; group III, persistent 
generalised lymphadenopathy; and group IV, other diseases. Subjects in group 
IV are assigned to one or more of six subgroups (A, B, C1, C2, D and E), two of 
which consist of subjects with AIDS defining conditions (C1 and D). 
 
The material is stratified into two groups regarding the initial CD4 value: 
<400 x 106 cells/l and >400 x 106 cells/l. This grouping was chosen based on 
results of previous therapeutic HIV vaccine trials (Bratt 1998).  
 
Three income groups based on the stated income for the year 1993 are used: 
low (<150,000 SEK), middle (150,000-200,000 SEK) and high (>200,000 SEK) 
(1 GBP = 11.71 SEK and 1 USD = 7.80 SEK (mean rate 1993. Source: 
Skandinaviska Enskilda Bank, Dept. of Foreign Currency)). 
 
Educational level is defined as follows: basic (compulsory school), middle 
(upper secondary school/high school) and high (university studies).  
 
Subjects who were being given anti-retroviral treatment (for example, AZT, 
ddI, ddC, 3TC) at the time of the investigation were compared with those who 
were not on such treatment. 
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Statistical methods 
 
Statistical calculations were performed with the assistance of the personal-
computer programmes SPSS for Windows, version 9.0.0. The criterion for 
statistical significance was p <0.05. Since not all the scales fulfilled the 
assumptions of normal distribution, mainly non-parametric methods were 
used: the Kruskal-Wallis test and the Mann-Whitney U-test (Polit 1996). The 
former test was used initially in order to identify differences in the 
comparisons involving three groups and the latter for comparisons involving 
two groups. The subgroups compared are described in the definitions and or 
results sections. The Mann-Whitney U-test was also used for pairwise, post hoc 
comparisons, following statistically significant, Kruskal-Wallis tests. In order 
to control the Type I error rate for multiple comparisons of three groups, a 
0.01667 significance criterion (Bonferroni adjustment) was used for the post 
hoc comparisons. In performing comparisons between the study group and the 
population groups, two-tailed, one-sample t-tests were used, since individual 
scores were not available in the published studies.  
 
Ethical Committee 
 
The study was approved by the Regional Ethical Committee at the Karolinska 
Institute. 
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RESULTS 
 
Sample 
 
The mean age was 37 years (SD 9, range  22-64 years). The inclusion criteria 
that stated an estimated CD4-value of >200 x 106 cells/l resulted in a mean 
CD4 count of 431 x 106 cells/l (SD 193, range 110-1080). The mean duration of 
HIV infection for the 57 participants, where it was possible to estimate this, 
was 4.9 years (SD 3.3, range 0.4-10 years). Further data are shown in Table 1. 
The 13 participants who were on anti-retroviral treatment had a mean of 11 
months since start of such treatment (SD 18, range 1.5 - 71 months). 
Furthermore, they had 247 x 106 cells/l in mean CD4 value (SD 115, range 
110-520) and their CDC status was as follows: CDC group III (n=3), CDC IV 
C1 (n=2), CDC IV C2 (n=6), and CDC IV D (n=2).  
 
The HRQOL and subjective health status related to population groups 
 
The results of the SWED-QUAL scales for the 72 men included in the study 
are shown in Table 2. Statistically significant differences between the study 
group and the Swedish population group were found for all scales, except for 
physical functioning, satisfaction with physical ability and pain. The 
respondents in the study group stated their HRQOL worse, as compared with 
the population group. 
 
The results of the HI for the 72 men in the study are shown in Table 3. The 
HIV-positive males stated their subjective health poorer (statistically 
significant), compared with that of the Stockholm population group.  
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The HRQOL and subjective health status related to medical variables 
 
CDC status 
 
Comparisons of the HRQOL between the groups of asymptomatic (CDC II/III; 
n=50), symptomatic (CDC IV, except C1 and D; n=16) and AIDS (CDC IV C1 
and D; n=6) subjects are shown in Table 4. Statistically significant differences 
were found between the three groups, as regarded several of the SWED-QUAL 
scales. Post hoc contrasts showed statistically significant differences between 
the asymptomatic group and the AIDS group, as regarded the following 
SWED-QUAL scales: physical functioning (p <0.01), mobility (p <0.001) and 
satisfaction with physical ability (p <0.01). Statistically significant differences 
were also found between the symptomatic group and the AIDS group, as 
regarded the SWED-QUAL scales for mobility (p <0.01), satisfaction with 
physical ability (p = 0.01), and role limitations due to physical health (p 
<0.01). No differences were seen, as regarded the HI. 
 
Anti-retroviral treatment 
 
On comparing the persons treated with anti-retroviral drugs at the time of 
investigation vs. those who were not treated with such drugs, the former group 
scored significantly lower on the following SWED-QUAL scales: physical 
functioning, mobility, satisfaction with physical ability, sleep problems and 
general health perception (Table 5). 
 
As regarded the total HI, as well as the EWB and the PWB subscales, the 
persons treated with anti-retroviral drugs stated their subjective health worse 
than persons not treated with these drugs (Table 5). 
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CD4 values  
 
Comparison of the two CD4 groups (CD4 <400 x 106 cells/l vs. CD4 >400 x 106 
cells/l) showed a statistically significant difference, as regarded the SWED-
QUAL physical functioning scale (p <0.05). Those with the higher number of 
CD4 values scored their physical functioning as better (median 100, range 85.7 
- 100) than those with the lower number of CD4 values (median 95.2, range 
47.6 - 100). No differences were seen, as regarded the HI. 
 
The HRQOL and subjective health status related to demographic 
variables 
 
Sick leave/disability pension 
 
On comparing the respondents who were on sick leave or had disability 
pensions at the time of the investigation (n=27) with those who were working 
full- or part-time (n=45), the former group scored statistically significantly 
lower on a majority of the SWED-QUAL scales (Table 6).  
 
As regarded the HI, statistically significant differences were found between 
the two groups, i.e. those on sick leave or with disability pensions scored lower 
on the total HI and the EWB and PWB subscales than those working full- or 
part-time (Table 6). 
 
Having a partner or not 
 
On comparing the participants who had partners with those who had not, no 
statistically significant differences were seen for either of the instruments.  
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Income level 
 
The comparisons of the SWED-QUAL scales between the three income groups 
(low, middle and high) showed statistically significant differences for some of 
the scales (Table 6). Post hoc contrasts showed statistically significant 
differences between the low- and the middle-income groups, as regarded the 
pain scale (p <0.01) and the general health perception scale (p = 0.016) and 
between the low- and the high-income groups, as regarded the general-health-
perception scale (p <0.01). Although a statistically significant difference was 
found between the groups on the scale for role limitations due to physical 
health (Kruskal-Wallis test), no statistically significant, pairwise, post hoc 
contrast between any of the stated groups could be identified (Mann-Whitney 
U-test).  
 
As regarded the HI, there was a statistically significant difference for the total 
HI score and for the EWB subscale (Table 6). Results of the post hoc contrasts 
showed that the low-income group scored lower than the high-income group on 
the EWB subscale (p <0.01). Although a statistically significant difference was 
found between the groups for the total HI (Kruskal-Wallis test), no 
statistically significant, pairwise, post hoc contrast between any of the stated 
groups could be identified (Mann-Whitney U-test). 
 
Education 
 
The comparisons of the SWED-QUAL scales according to the three education 
groups (basic, middle and high) showed statistically significant differences for 
two of the scales (Table 6). Post hoc contrasts showed statistically significant 
differences between the basic- and the high-education groups, as regarded the 
pain scale (p <0.001). Statistically significant, post hoc contrasts were also 
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found between the basic- and the middle-education groups, as regarded the 
sleep problems scale (p <0.01).  
 
As regarded the HI, statistically significant differences between the groups 
were found for the PWB subscale (Table 6). Results of the post hoc contrasts 
for the PWB subscale showed that the basic-education group scored lower than 
the middle-education group (p = 0.013). 
 
Reliability of SWED-QUAL and HI 
 
In the present study, Cronbach’s  reliability estimates for the 11 SWED-
QUAL, multi-item scales indicated good internal consistency, i.e. for physical 
functioning 0.79, role limitations due to physical health 0.93, pain 0.92, 
positive affect 0.91, absence of negative affect 0.87, role limitations due to 
emotional health 0.93, sleep 0.85, satisfaction with family life 0.85, relation to 
partner 0.79, sexual functioning 0.83, and general health perception 0.88.  
 
Good internal consistency was also indicated for the total HI and for the EWB 
subscale ( 0.86 and 0.80 respectively). The internal consistency for the PWB 
subscale was  0.68. 
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DISCUSSION 
 
Although HIV infection is normally characterised by a long period (several 
years) with no or minor symptoms, the infection affects several dimensions of 
the HRQOL. In the present investigation, the SWED-QUAL and Health Index 
instruments were used in order to assess the HRQOL and the subjective 
health status in 72 HIV carriers. The results of the present study indicated 
that these two instruments are reliable and valid for use in HIV-positive 
patients. Adequate internal consistency was found for both instruments. Both 
instruments also showed to have discriminant validity. Although a high 
proportion of the patients scored highest possible values in different scales, the 
instruments discriminated between groups in several of the subgroup 
comparisons (for example the working status groups (working vs. not working) 
and the anti-retroviral treatment groups (treatment vs. no treatment) 
respectively). The shorter HI (approx. 5 minutes to complete) however, was a 
little less able to discriminate between groups than the longer SWED-QUAL 
(approx. 15 minutes to complete). The instruments’ sensitivities to changes 
over time have still to be investigated.  
 
The overall result showed that the investigated group of patients had a clearly 
negatively affected HRQOL and subjective health status, compared with the 
general-population samples used. In order to discover whether the differences 
between the study group and the population groups depend on the HIV 
infection or have other influences (for example, sexual orientation), further 
investigations are needed.  
 
On comparing the investigated group with the population groups, it was the 
dimensions of emotional well-being that were found to be most affected. These 
results may be explained by the fact that the subjects in this study consisted of 
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relatively healthy HIV carriers, who are not so physically affected by the 
disease. Similar results have also been shown by Ragsdale & Morrow 1990.  
 
The instruments used in the present study have also been used in studies 
investigating the HRQOL and subjective health status in other disease groups, 
for example, patients with glaucoma, diabetes mellitus, breast cancer and 
urostomies (Nordström et al. 1992; Larsen et al. 1996; Wändell et al. 1997a; 
Wändell et al. 1997b). It seems that these groups are more physically affected 
and less emotionally affected than the investigated HIV group. This seems 
logical, as a majority of the studied group had no or minor physical symptoms 
of their infection. 
  
When the HRQOL and subjective health status were compared according to 
the medical and demographic variables for the different subgroups within the 
studied group, differences in the physical-dimension scales were most 
prominent. The disease stage (i.e. CDC status) seemed to affect the HRQOL. 
Patients included in the AIDS group scored lower on several SWED-QUAL 
physical-dimension scales, compared with the asymptomatic and symptomatic 
disease groups. Similar results have also been shown by several investigators, 
using various instruments (Ragsdale & Morrow 1990; Wu et al. 1991; Lubeck 
& Fries 1992; Schag et al. 1992; Wachtel et al. 1992; Revicki et al. 1995; 
Hughes et al. 1997; Peterman et al. 1997; Smith et al. 1997). It should be noted 
that Burgess et al., like the present investigators, found significant relations 
between the disease stage and the scales measuring physical and functional 
aspects of the quality of life and, also like the present investigators, they found 
only a few significant relations on most of the psychological measures and 
global ratings of the quality of life (Burgess et al. 1993).  
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The patients who were on anti-retroviral treatment were more physically 
affected and stated their general health as worse, compared with those not so 
treated. Lenderking et al. however, found better perceived health in patients 
experienced in anti-retroviral treatment, compared with patients 
inexperienced in this treatment (Lenderking et al. 1997). Since the present 
study was not randomised according to anti-retroviral treatment, there could 
be some medical differences between the groups. The treated patients seemed 
to have lower CD4 counts, and more patients seemed to be symptomatic, 
compared with those not treated. It remains to investigate if the affected 
HRQOL was induced by disease stage or by side effects of the ongoing 
treatment. Further studies are needed to follow the disease progression’s 
impact on HRQOL and to follow the effect of anti-retroviral treatment on the 
HRQOL.  
 
CD4 values seemed to be poor predictors of how the HIV-infected subjects 
stated their HRQOL. Only one of the measures used, the SWED-QUAL 
physical-function scale, differed significantly as between the two CD4 
subgroups. However, in this study, only a small fraction had CD4 values <200. 
Similar results have also been found by other groups (Ganz et al. 1993; 
Lenderking et al. 1997; Murri et al. 1997)  
 
Studies highlighting differences between HIV carriers who are able to work 
and those who are not able to work are scarce. Not surprisingly, the present 
investigation showed that those who were on sick leave or had disability 
pensions stated their health status as worse, compared with those working 
full- or part-time. Similar results were also found by Hansen et al. in a HIV-
positive sample (Hansen et al. 1993) and by Nordström et al. in a group of 
patients with ileal-conduit, urinary diversion (Nordström et al. 1992). 
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A study by Kendall showed, in a sample of HIV-positive, homosexual men, 
that close relations were the most important aspect of well-being (Kendall 
1996). Moreover, it has been shown that living with a partner or not has an 
impact on the perceived well-being of pre-dialysis patients (Klang et al. 1996) 
and colo-rectal- and gastric-cancer patients (Forsberg et al. 1995). One could 
thus expect that having a partner or not would influence the HRQOL. In the 
present study, however, having a partner or not had no impact on the subjects’ 
stated HRQOL. Similar findings have also been made by Hansen, Norlin & 
Björvell who found no differences between the HIV patients who lived with 
someone vs. those who lived alone (Hansen et al. 1993).  
 
Basic education and low income were related to poor HRQOL in the present 
study. These results confirm the findings of previous studies (Stewart et al. 
1988; Wachtel et al. 1992; Cunningham et al. 1995; Holmes & Shea 1997).  
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CONCLUSIONS AND IMPLICATIONS FOR PRACTICE 
 
In conclusion, in the group of HIV-positive subjects, their disease seems to 
have a negative impact on the emotional well-being, compared with the 
reference groups. In combination with the fact that current anti-retroviral 
treatment options are expected to decrease the HIV-disease progression rate, 
this increases still more the importance of taking into account aspects of the 
patients’ emotional well-being in nursing, as well as in medical care and 
interventions. One example could be multiprofessional support groups aiming 
to increase the patient’s knowledge about the disease, treatment effects and 
how to cope with the situation. Such support groups could also give the 
patients the opportunity to exchange experiences with other people living with 
HIV and to decrease social isolation. Moreover, since there were major 
fluctuations of the impact on the HRQOL and subjective health status within 
the study group, this calls for individualised caring programs. 
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Table 1. Demographic and medical data regarding a Swedish sample of HIV- 
infected men (n=72) 
 No of subjects  Percentage 
Mode of transmission   
     Male to male  69 96 
     Female to male  3 4 
Ethnic group   
     White 68 94 
     Asian 3 4 
     Other (mixed) 1 2 
CDC status    
     II 20 28 
     III 30 42 
     IV A 1 1 
     IV C1 2 3 
     IV C2 15 21 
     IV D 4 5 
CD4 group   
     >400 x 106 cells/l 37 51 
     <400 x 106 cells/l 35 49 
Anti-retroviral treatment, Yes/No 13/59 18/82 
Sick leave, Yes/No 16/56 22/78 
Disability pension, Yes/No 11/61 15/85 
Having a partner, Yes/No 40/31 56/43 
     Not stated 1 1 
Income   
     Low  (<150,000 SEK) 21 29 
     Medium (150,000-200,000 SEK) 33 46 
     High (>200,000 SEK) 15 21 
     Not stated 3 4 
Education   
     Basic 11 15 
     Medium 29 40 
     High 28 39 
     Not stated 4 6 
  
Table 2. The Swedish Health-Related Quality of Life Questionnaire. Comparisons of  
the HIV-seropositive males (n=72) with the Swedish population group (n=390). 
 HIV-seropositive males 
 
Swedish 
population 
group 
p-value 
 Mean SD Mean  
SWED-QUAL     
Physical functioning 94.8 10.1 94.1 NS 
Mobility 95.4 12.9 98.8 <0.05 
Satisfaction with physical ability 77.0 26.2 78.5 NS 
Role limitations due to physical 
health 
78.7 31.0 92.0 <0.01 
Pain 80.5 27.8 85.9 NS 
Positive affect 65.5 26.1 76.7 <0.001 
Absence of negative affect 59.4 29.2 76.3 <0.001 
Role limitations due to emotional 
health 
79.4 30.4 89.9 <0.01 
Sleep problems 65.3 28.1 75.8 <0.01 
Satisfaction with family life 63.8 26.7 83.5 <0.001 
Relation to partner 76.4 19.9 85.4 <0.01 
Sexual functioning 76.6 27.5 91.5 <0.001 
General health perception 67.6 26.2 85.2 <0.001 
NS = non-significant 
Table 3. Health Index. Comparison of the HIV-seropositive males (n=72) with a  
Stockholm male population group (n=60). 
 HIV-seropositive males 
 
Stockholm 
population 
group 
p-value 
 Mean SD Mean  
Health Index (HI)     
Total (nine items)* 28.0 4.4 30.5 <0.001 
Total (ten items) 31.1 5.0   
Emotional well-being (four items) 11.6 2.3   
Physical well-being (five items) 16.4 2.5   
* The general-health item was excluded in the Stockholm population group in calculating the total  
HI. Thus, the score ranges between 9 and 36. 
Table 4. Health-related quality of life related to disease stage. Median and range are given  
for the scales on which statistically significant differences were found between groups. 
 Disease stage 
 
 
 Asympt. Sympt. AIDS  
 Median 
(Range) 
Median 
(Range) 
Median 
(Range) 
p-valuea 
SWED-QUAL     
Physical functioning 100 
(71.4-100) 
100 
(76.2-100) 
81.0 
(47.6-100) 
<0.05 
Mobility 100 
(33.3-100) 
100 
(66.7-100) 
66.7 
(66.7-100) 
<0.001 
Satisfaction with physical ability 100 
(0-100) 
66.7 
(33.3-100) 
50.0 
(0-66.7) 
<0.05 
Role limitations due to physical health 100 
(0-100) 
100 
(33.3-100) 
61.1 
(22.2-88.9) 
<0.05 
Pain - - - - 
Positive affect - - - - 
Absence of negative affect - - - - 
Role limitations due to emotional health - - - - 
Sleep problems - - - - 
Satisfaction with family life - - - - 
Relation to partner - - - - 
Sexual functioning - - - - 
General health perception - - - - 
a
 Kruskal-Wallis test 
Table 5. Health-related quality of life and subjective health status related to anti- 
retroviral treatment. Median and range are given for the scales on which statistically  
significant differences were found between groups. 
 Anti-retroviral treatment  
 Treated Not treated  
 Median 
(Range) 
Median 
(Range) 
p-valuea 
SWED-QUAL    
Physical functioning 95.2 
(47.6-100) 
100 
(71.4-100) 
<0.01 
Mobility 100 
(66.7-100) 
100 
(33.3-100) 
<0.01 
Satisfaction with physical ability 66.7 
(0-100) 
100 
(0-100) 
<0.05 
Role limitations due to physical health - - - 
Pain - - - 
Positive affect - - - 
Absence of negative affect - - - 
Role limitations due to emotional health - - - 
Sleep problems 42.9 
(16.7-92.9) 
78.6 
(14.3-100) 
<0.05 
Satisfaction with family life - - - 
Relation to partner - - - 
Sexual functioning - - - 
General health perception 44.4 
(25.0-88.9) 
77.8 
(11.1-100) 
<0.01 
Health Index (HI)    
Total 28 
(20-35) 
33 
(20-40) 
<0.05 
Emotional well-being 10 
(7-13) 
12 
(6-16) 
<0.05 
Physical well-being 15 
(10-19) 
17 
(11-20) 
<0.05 
a
 Mann Whitney U-test 
Table 6. Health-related quality of life and subjective health status related to demographic variables. Median and range are given for the scales on which statistically 
significant differences were found between groups. 
 Working status 
 
 
Income level 
 
 
Educational level 
 
 
 Leave/pens. Working  Low Middle High  Basic Middle High  
 Median 
(Range) 
Median 
(Range) 
p-valuea Median 
(Range) 
Median 
(Range) 
Median 
(Range) 
p-valueb Median 
(Range) 
Median 
(Range) 
Median 
(Range) 
p-valueb 
SWED-QUAL            
Physical functioning 95.2 
(47.6-100 
100 
(71.4-100) 
<0.001 - - - - - - - - 
Mobility 100 
(66.7-100) 
100 
(33.3-100) 
<0.05 - - - - - - - - 
Satisfaction with physical 
ability 
66.7 
(0-100) 
100 
(33.3-100) 
<0.01 - - - - - - - - 
Role limitations due to 
physical health 
55.6 
(0-100) 
100 
(0-100) 
<0.001 88.9 
(22.2-100) 
100 
(0-100) 
100 
(0-100) 
<0.05 - - - - 
Pain 56.7 
(5.6-100) 
100 
(11.1-100) 
<0.001 69.4 
(11.1-100) 
100 
(26.4-100) 
100 
(5.6-100) 
<0.05 60.4 
(21.7-100) 
100 
(11.1-100) 
100 
(5.6-100) 
<0.01 
Positive affect - - - - - - - - - - - 
Absence of negative affect - - - - - - - - - - - 
Role limitations due to 
emotional health 
77.8 
(0-100) 
100 
(0-100) 
<0.01 - - - - - - - - 
Sleep problems 42.9 
(14.3-100) 
83.9 
(16.7-100) 
<0.01 - - - - 35.7 
(21.4-92.9) 
82.1 
(14.3-100) 
75.0 
(16.7-100) 
<0.05 
Satisfaction with family life - - - - - - - - - - - 
Relation to partner - - - - - - - - - - - 
Sexual functioning - - - - - - - - - - - 
General health perception 58.3 
(11.1-100) 
83.3 
(16.7-100) 
<0.01 44.4 
(16.7-100) 
77.8 
(11.1-100) 
88.9 
(30.6-100) 
<0.01 - - - - 
Health Index (HI)            
Total 28 
(20-39) 
34 
(20-40) 
<0.01 29 
(20-39) 
33 
(21-39) 
34 
(20-40) 
<0.05 - - - - 
Emotional well-being 11 
(8-15) 
12 
(6-16) 
<0.05 11 
(6-15) 
12 
(8-16) 
12 
(8-16) 
<0.05 - - - - 
Physical well-being 15 
(10-20) 
17 
(12-20) 
<0.05 - - - - 15 
(12-18) 
17 
(11-20) 
17.5 
(10-20) 
<0.05 
a
  Mann-Whitney U-test; b Kruskal-Wallis test 
